Leidy E. Pavas-Zapata
Derio, PV 48160, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Metabolic dysfunction-associated steatotic liver disease alters brain function and behavior: Insights from liver-targeted siRNA therapy.
Journal: Science advances
Published: October 22, 2025
Hepatic HuR modulates glucose metabolism through the C/EBPβ/PCK1 pathway.
Journal: Molecular metabolism
Published: October 19, 2025
Inhibition of the SerpinB3/protease-activated receptor 2 axis reduces liver cancer development and affects lipid metabolism.
Journal: British journal of cancer
Published: June 26, 2025
NEDD8-specific protease 1 deficiency as a novel driver of hepatoblastoma development through dysregulation of the CAND1-NEDD8 pathway.
Journal: Hepatology (Baltimore, Md.)
Published: April 03, 2025
Protocol for pull-down capture of ubiquitinated and NEDDylated liver proteins from transgenic biotinylated ubiquitin and NEDD8 mice.
Journal: STAR protocols
Published: November 15, 2024
Modulatory effects of CNNM4 on protein- l -isoaspartyl- O -methyltransferase repair function during alcohol-induced hepatic damage.
Journal: Hepatology (Baltimore, Md.)
Published: March 23, 2024
Neddylation inhibition prevents acetaminophen-induced liver damage by enhancing the anabolic cardiolipin pathway.
Journal: Cell reports. Medicine
Published: September 27, 2023
SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer.
Journal: Cell reports
Published: September 30, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026